Oral mineralocorticoid antagonists for recalcitrant central serous chorioretinopathy

PURPOSE: To evaluate the effect and tolerance of oral mineralocorticoid antagonists, eplerenone and/or spironolactone, in recalcitrant central serous chorioretinopathy. METHODS: Retrospective consecutive observational case series. Primary outcome measures included central macular thickness (CMT, μm)...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Clin Ophthalmol
Egile Nagusiak: Chin, Eric K, Almeida, David RP, Roybal, C Nathaniel, Niles, Philip I, Gehrs, Karen M, Sohn, Elliott H, Boldt, H Culver, Russell, Stephen R, Folk, James C
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Dove Medical Press 2015
Gaiak:
Original Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4540165/
https://ncbi.nlm.nih.gov/pubmed/26316684
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OPTH.S86778
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak